231 filings
Page 4 of 12
8-K
4u433rjdqd3kny4b18p
10 May 23
Motus GI Reports First Quarter 2023 Financial Results
4:05pm
8-K
erdeqm10yh 2e
13 Apr 23
Departure of Directors or Certain Officers
4:15pm
8-K
bj3v1r5e9v17e63er
5 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
S-8
nj75qfux
3 Apr 23
Registration of securities for employees
2:46pm
8-K
8fbe5qy 2mu9t
31 Mar 23
Motus GI Reports Fourth Quarter and Full Year 2022 Financial Results
4:05pm
8-K
rxvt3byv
14 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
8-K
us5 fv9jaseo0
10 Jan 23
Motus GI Announces Exploration of Strategic Alternatives to Enhance Shareholder Value
8:40am
8-K
pczkh4d4did5cuo
21 Dec 22
Motus GI Announces Improvement of Pure-Vu® EVS System for Use in Upper Gastrointestinal (GI) Bleeding Procedures Following Successful Pre-Clinical Tests
8:12am
8-K
tvo4vo1a
14 Nov 22
Motus GI Reports Third Quarter 2022 Financial Results
4:14pm
8-K
mttmgv9ke3n3
24 Oct 22
Motus GI Announces Positive Clinical Data for Pure-Vu EVS in Three Poster
8:40am
8-K
7dl4z3td runr8cpp4
6 Oct 22
Motus GI Granted a U.S. Patent for Prepless Colonoscopy Methods
9:15am
8-K
z2d7ue1
29 Sep 22
Regulation FD Disclosure
9:15am
8-K
pp8je
24 Aug 22
Amendments to Articles of Incorporation or Bylaws
5:00pm
8-K
cqxf0mt
11 Aug 22
Motus GI Reports Second Quarter 2022 Financial Results
4:10pm
8-K
vjwf29c48
11 Aug 22
Other Events
8:05am
8-K
6ohs l7nh
26 Jul 22
Material Modifications to Rights of Security Holders
9:00am
8-K
px68 ugfu9z
30 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm